Hsbc Holdings PLC Lannett CO Inc Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$4.17 - $5.74 $5,875 - $8,087	-1,409 Reduced 1.61%	86,348 $403,000
Q1 2021 May 14, 2021	SELL	$5.28 - $9.64 $3,975 - $7,258	-753 Reduced 0.85%	87,757 $463,000
Q4 2020 Feb 12, 2021	SELL	$5.75 - $7.13 $132 - $163	-23 Reduced 0.03%	88,510 $577,000
Q3 2020 Nov 12, 2020	SELL	$4.9 - $7.12 $916 - $1,331	-187 Reduced 0.21%	88,533 $538,000
Q2 2020 Aug 14, 2020	SELL	$6.43 - $9.86 $4,076 - $6,251	-634 Reduced 0.71%	88,720 $644,000
Q1 2020 May 15, 2020	SELL	$6.36 - $10.05 $4,700 - $7,426	-739 Reduced 0.82%	89,354 $635,000
Q4 2019 Feb 14, 2020	BUY	$8.49 - $12.81 $676,593 - $1.02 Million	79,693 Added 766.28%	90,093 $793,000
Q3 2019 Nov 14, 2019	BUY	$5.58 - $14.47 $58,032 - $150,488	10,400 New	10,400 $116,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.